Develops innovative monoclonal antibodies against cancer
GamaMabs Pharma has raised €18M across 2 funding rounds from 4 investors, most recently a Series B round in Dec 2015. Based in Toulouse, France; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2015-12-01 | Series B | €15M | Alto Invest,Edmond de Rothschild Venture Capital,iXO Private Equity | View deal → |
| 2013-09-01 | Series A | €3.1M | Bpifrance | View deal → |
